The DLB Lakers enter into the state tournament on a 10 game winning streak, and they’ll most defiantly be looking to carry ...
Dementia with Lewy bodies (DLB) is a complex condition that shares features with both Alzheimer’s disease and Parkinson’s ...
CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...
NYSE DLB opened at $81.65 on Tuesday. Dolby Laboratories, Inc. has a twelve month low of $66.35 and a twelve month high of $89.66. The stock has a market cap of $7.79 billion, a PE ratio of 30.02 ...
JonesResearch upgraded CervoMed (CRVO) to Buy from Hold with a $15 price target arguing that the company’s latest data from ...
A recent study provided key insights into brain degeneration in DLB, which may help clinicians better monitor this ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB)Phase 2 SHINE Data Show Dramatic Slowing of ...